BBW_Source (Pvt) Ltd, trading as Zose Pharma, is a Botswana-registered private limited company founded in 2013. Strategically located at Plot 4612, Mogoditshane - Gabane Industrial Area, Zose Pharma is led by a visionary team of healthcare professionals whose combined expertise spans pharmaceutical manufacturing, healthcare administration, and business operations.
Zose Pharma is pioneering Botswana's pharmaceutical landscape as the first local manufacturer of oral tablets and dry powder formulations, addressing the urgent need for affordable, high-quality medicines across the Southern African region. With groundbreaking planned for early 2026, the Gabane-based facility will be the first of its kind in the country, offering a transformative opportunity for investors seeking scalable, socially impactful ventures in healthcare.
Zose Pharma's upcoming facility will be Botswana's first primary pharmaceutical manufacturing plant, designed to meet rising healthcare demands both locally and regionally. Upon launch in 2026, the facility will feature:
The plant design has received pre-approval from BoMRA, ensuring full compliance with WHO Good Manufacturing Practices (GMP). This significantly reduces regulatory risk and accelerates the path to operational readiness.
Zose Pharma aims to supply WHO-GMP-compliant generic medicines to Botswana's healthcare system and the broader SADC market, filling a critical gap in reliable, cost-effective pharmaceutical products.
Zose Pharma represents a high-impact, future-forward investment in a sector marked by:
This is more than a business—it's a catalyst for health equity, industrial innovation, and regional resilience.